8-KEarnings & ResultsExhibits & Filings

BRISTOL MYERS SQUIBB CO 8-K Report, Financial Results (Aug 31, 2006)

Filed August 31, 2006For Securities:BMYCELG-RIBMYMP

Summary

Bristol-Myers Squibb Company (BMY) filed an 8-K on August 31, 2006, to report additional supplemental financial information. This information, posted on the company's website (www.bms.com), pertains to net sales, months on hand, and estimated demand for key products across its International Pharmaceutical, Nutritionals, and Other Health Care segments as of June 30, 2006. Historical data for net sales and months on hand as of March 31, 2006, June 30, 2005, and March 31, 2005, were also provided. This filing offers investors a deeper look into the operational performance and inventory management of BMY's various business segments. The focus on "months on hand" and "estimated demand" suggests an effort to provide transparency regarding inventory levels and product demand, which can be crucial indicators of future sales trends and supply chain efficiency. Investors should review this supplemental data to assess the company's product portfolio health and its ability to meet market demand.

Key Highlights

  • 1BMY filed an 8-K on August 31, 2006, reporting supplemental financial information.
  • 2The supplemental data includes net sales, months on hand, and estimated demand for key products.
  • 3Information is provided for International Pharmaceutical, Nutritionals, and Other Health Care segments.
  • 4Data points are available as of June 30, 2006, with historical data for March 31, 2006, June 30, 2005, and March 31, 2005.
  • 5The supplemental information was posted on the company's official website (www.bms.com).
  • 6This filing is intended to provide investors with additional operational and inventory insights.
  • 7The information is incorporated by reference as Exhibit 99.1 to the Form 8-K.

Frequently Asked Questions

This 8-K filing discloses additional supplemental financial information, including net sales, months on hand, and estimated demand for key products within Bristol-Myers Squibb's International Pharmaceutical, Nutritionals, and Other Health Care segments. Historical data for net sales and months on hand from prior periods is also included.

The additional supplemental information was posted on Bristol-Myers Squibb Company's official website at www.bms.com. It is also furnished and incorporated by reference as Exhibit 99.1 to this Form 8-K.

'Months on hand' refers to the amount of inventory the company has relative to its sales rate, indicating how long current inventory would last. 'Estimated demand' provides insight into market consumption of the company's products. For investors, these metrics can signal inventory management efficiency, potential supply chain issues, and forward-looking demand trends for BMY's products.

The supplemental information provides data as of June 30, 2006, for net sales, months on hand, and estimated demand. Net sales and months on hand data are also provided for historical periods: March 31, 2006, June 30, 2005, and March 31, 2005.